Acurx Pharmaceuticals, Inc. (ACXP)
1.43
+0.01
(+0.70%)
USD |
NASDAQ |
Sep 08, 16:00
1.435
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Price to Book Value : 0.8215 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.8215 |
| September 04, 2026 | 0.8158 |
| September 03, 2026 | 0.8043 |
| September 02, 2026 | 0.8215 |
| September 01, 2026 | 0.8043 |
| August 31, 2026 | 0.833 |
| August 28, 2026 | 0.8273 |
| August 27, 2026 | 0.8388 |
| August 26, 2026 | 0.8215 |
| August 25, 2026 | 0.81 |
| August 24, 2026 | 0.8043 |
| August 21, 2026 | 0.8445 |
| August 20, 2026 | 0.833 |
| August 19, 2026 | 0.8273 |
| August 18, 2026 | 0.8273 |
| August 17, 2026 | 0.9479 |
| August 14, 2026 | 0.8014 |
| August 13, 2026 | 0.8503 |
| August 12, 2026 | 0.8847 |
| August 11, 2026 | 0.8445 |
| August 10, 2026 | 0.879 |
| August 07, 2026 | 0.8847 |
| August 06, 2026 | 0.8388 |
| August 05, 2026 | 0.8445 |
| August 04, 2026 | 0.8215 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.8215 |
| July 31, 2026 | 0.8273 |
| July 30, 2026 | 0.8158 |
| July 29, 2026 | 0.7986 |
| July 28, 2026 | 0.81 |
| July 27, 2026 | 0.8215 |
| July 24, 2026 | 0.8158 |
| July 23, 2026 | 0.833 |
| July 22, 2026 | 0.8445 |
| July 21, 2026 | 0.8732 |
| July 20, 2026 | 0.8905 |
| July 17, 2026 | 0.8905 |
| July 16, 2026 | 0.9135 |
| July 15, 2026 | 1.005 |
| July 14, 2026 | 0.9479 |
| July 13, 2026 | 0.9077 |
| July 10, 2026 | 0.8617 |
| July 09, 2026 | 0.8388 |
| July 08, 2026 | 0.7813 |
| July 07, 2026 | 0.833 |
| July 06, 2026 | 0.9077 |
| July 02, 2026 | 0.9192 |
| July 01, 2026 | 0.879 |
| June 30, 2026 | 0.8905 |
| June 29, 2026 | 0.8119 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.633 |
| Alnylam Pharmaceuticals, Inc. | 25.69 |
| Anika Therapeutics, Inc. | 2.051 |
| Savara, Inc. | 7.907 |
| Vericel Corp. | 5.404 |
Price to Book Value Related Metrics
| Price | 1.43 |
| Earnings Yield | -213.0% |
| Market Cap | 6.697M |